Back to top

Early Data Milestone: BeOne Medicines Advances BGB-15025 in Immune Oncology

BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines’ latest study update centers on an early stage trial of...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BeOne Medicines Ltd. - Sponsored ADR (ONC)